Table 3.

Comparison of children who were successfully treated with a single cycle of albendazole with children who required additional courses of chemotherapy

	Successful treatment (n = 47)	Treatment failure (n = 19)
Gender (female/male)	23 (49%)/24 (51%)	8 (42%)/11 (58%)
Place of residence (town/countryside)	28 (60%)/19 (40%)	8 (42%)/11 (58%)
Total eosinophil count before treatment (cells/μL)	498 ± 426	780 ± 522*
Total IgE levels before treatment (IU/mL)	160 ± 201	229 ± 215
Specific Toxocara IgG antibody titre before treatment (NTU)	20.8 ± 9.0	28.8 ± 12.6**

Laboratory findings presented as mean ± SD

*p < 0.05; **p < 0.01